Bellicum Cash Flow - Quarterly (NASDAQ:BLCM)

Add to My Stocks
$6.2 $0.12 (1.9%) BLCM stock closing price Sep 17, 2018 (Closing)

The cash flow statement is one of the reports a publicly traded company like Bellicum needs to disclose. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Bellicum profits one has to check the income statement and for Bellicum debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Bellicum stock analysis. Bellicum had a negative net income cash flow of $-47.02M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. BLCM increase in investments stood at a value of $4.3M for the latest quarter 2018 Q2.

View and download details of Bellicum cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow3.61M1.67M4.53M3.27M2.1M-3.14M2.24M1.35M-
Net Increase (Decrease) in Assets Liabilities-1.47M-1.11M-1.08M-3.78M-4.85M-4.82M3.3M1.84M-0.52M-
Cash From (used in) Discontinued Operations----------
Other Adjustments Net7.18M3.6M15.34M10.21M6.55M3.36M12.34M9.26M6.2M3.06M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-1.06M-0.41M-12.09M-10.55M-7.57M-1.59M-7.22M-5.78M-4.56M-2.29M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments5.35M10.96M8.84M9.25M11M9.93M9.27M-0.34M-6.84M-9.83M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares67.75M-66.63M66.18M66.03M65.44M1.14M---
Issuance (Repayment) of Debt Securities-0.02M-0.01M12.28M-0.01M-0.01M-19.98M-0.01M-0.01M14.99M
Increase (Decrease) in Bank & Other Borrowings---10M10M10M-20M15M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.44M-0.07M-0.07M-0.1M-0.19M-0.19M-0.19M-0.19M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year45.03M42.78M70.24M191.6M11.16M1.63M7.9M---
Cash & Equivalents at Year End79.36M37.72M45.02M57.41M79.53M104.01M42.78M48.69M49.54M61.79M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Bellicum stock comparison chart provides an easy way to compare the stock price with peers along with details of Bellicum stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Bellicum is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Bellicum stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Bellicum lost $-37.7M cash from operations. It is important to check this to see where the company is getting its money from.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $4.3M for BLCM stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Bellicum and its owners and creditors and was $67.73M till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Bellicum Cash Flow

Quarterly Cash Flow Statements For Bellicum Pharmaceuticals Inc Peers

Cellectis cash flow, GlobeImmune cash flow, Marinus Pharma cash flow, Pfizer cash flow